Skip to content
Pharma Observatory a Scientist.com platform
  • Trial site

Trial site location from the registry's own city and country. GeoNames (geonames.org).

Clinical trial site

University of Kansas Medical Center

University of Kansas Medical Center in Kansas City, Kansas, United States is listed as a site for 1,285 registered clinical trials, 285 of them ongoing.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Registered trials 1,285
Ongoing 285

This page covers the site record University of Kansas Medical Center in Kansas City, Kansas, United States: the trials that list it by this name in ClinicalTrials.gov. The same place can be registered under other names, each with its own page and its own trials, and a count here is a number of registered trials, not of patients enrolled. The organization of the same name, University of Kansas Medical Center, also sponsors trials.

Get the University of Kansas Medical Center report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Trials by phase

Registered trials that list this site, by trial phase. 1,285 trials counted.

  • Phase 1 75 trials
  • Phase 1/2 33 trials
  • Phase 2 291 trials
  • Phase 2/3 28 trials
  • Phase 3 289 trials
  • Phase 4 57 trials
  • Not applicable 316 trials
  • Observational 186 trials
  • Expanded access 10 trials

Trials by status

The registry's own status summary: Ongoing, Completed, Terminated or Other.

  • Ongoing 287 trials
  • Completed 767 trials
  • Terminated 196 trials
  • Other 35 trials

Trials over time

Trials registered with a start date in each year, 1990 onward, most recent years first.

Trials over time, by phase

  • Phase 1
  • Phase 1/2
  • Phase 2
  • Phase 2/3
  • Phase 3
  • Phase 4
  • Not applicable
  • Observational

Top of scale: 86

1994: 5 trials (Phase 3 3, Phase 2 2) 1995: 5 trials (Phase 3 3, Phase 2 2) 1996: 4 trials (Phase 3 1, Phase 2 2, Phase 1 1) 1997: 13 trials (Observational 2, Phase 3 6, Phase 2 4, Phase 1 1) 1998: 20 trials (Not applicable 1, Phase 3 4, Phase 2 11, Phase 1 4) 1999: 16 trials (Observational 2, Phase 3 5, Phase 2 7, Phase 1 2) 2000: 20 trials (Phase 3 10, Phase 2 8, Phase 1 2) 2001: 16 trials (Phase 4 1, Phase 3 3, Phase 2 12) 2002: 9 trials (Observational 1, Phase 2/3 1, Phase 2 5, Phase 1/2 1, Phase 1 1) 2003: 16 trials (Observational 3, Not applicable 1, Phase 3 4, Phase 2 6, Phase 1/2 1, Phase 1 1) 2004: 14 trials (Observational 1, Not applicable 1, Phase 4 2, Phase 3 5, Phase 2 3, Phase 1/2 1, Phase 1 1) 2005: 22 trials (Observational 4, Not applicable 2, Phase 3 4, Phase 2 11, Phase 1 1) 2006: 32 trials (Observational 5, Not applicable 7, Phase 3 14, Phase 2 5, Phase 1 1) 2007: 40 trials (Observational 3, Not applicable 12, Phase 4 5, Phase 3 11, Phase 2/3 2, Phase 2 6, Phase 1 1) 2008: 36 trials (Observational 3, Not applicable 9, Phase 4 3, Phase 3 8, Phase 2/3 1, Phase 2 9, Phase 1/2 1, Phase 1 2) 2009: 38 trials (Observational 1, Not applicable 11, Phase 4 1, Phase 3 10, Phase 2/3 1, Phase 2 13, Phase 1/2 1) 2010: 35 trials (Observational 9, Not applicable 8, Phase 4 1, Phase 3 7, Phase 2 6, Phase 1 4) 2011: 40 trials (Observational 5, Not applicable 8, Phase 4 1, Phase 3 6, Phase 2/3 2, Phase 2 15, Phase 1/2 1, Phase 1 2) 2012: 36 trials (Observational 9, Not applicable 9, Phase 3 7, Phase 2/3 1, Phase 2 4, Phase 1/2 3, Phase 1 3) 2013: 39 trials (Observational 6, Not applicable 10, Phase 4 2, Phase 3 12, Phase 2 7, Phase 1 2) 2014: 42 trials (Observational 4, Not applicable 17, Phase 4 3, Phase 3 10, Phase 2 5, Phase 1/2 1, Phase 1 2) 2015: 47 trials (Observational 8, Not applicable 8, Phase 4 5, Phase 3 10, Phase 2/3 1, Phase 2 11, Phase 1/2 1, Phase 1 3) 2016: 53 trials (Observational 7, Not applicable 17, Phase 4 3, Phase 3 13, Phase 2/3 2, Phase 2 9, Phase 1 2) 2017: 76 trials (Observational 6, Not applicable 21, Phase 4 7, Phase 3 18, Phase 2/3 4, Phase 2 16, Phase 1/2 2, Phase 1 2) 2018: 78 trials (Observational 14, Not applicable 22, Phase 4 6, Phase 3 15, Phase 2 13, Phase 1/2 3, Phase 1 5) 2019: 64 trials (Observational 6, Not applicable 20, Phase 4 3, Phase 3 18, Phase 2/3 2, Phase 2 9, Phase 1/2 4, Phase 1 2) 2020: 78 trials (Observational 15, Not applicable 23, Phase 4 3, Phase 3 11, Phase 2 16, Phase 1 10) 2021: 62 trials (Observational 18, Not applicable 13, Phase 4 2, Phase 3 7, Phase 2/3 3, Phase 2 9, Phase 1/2 5, Phase 1 5) 2022: 86 trials (Observational 16, Not applicable 25, Phase 4 2, Phase 3 17, Phase 2/3 3, Phase 2 16, Phase 1 7) 2023: 60 trials (Observational 11, Not applicable 16, Phase 4 2, Phase 3 6, Phase 2/3 3, Phase 2 20, Phase 1/2 1, Phase 1 1) 2024: 72 trials (Observational 12, Not applicable 20, Phase 4 4, Phase 3 18, Phase 2/3 1, Phase 2 8, Phase 1/2 6, Phase 1 3) 2025: 59 trials (Observational 9, Not applicable 21, Phase 4 1, Phase 3 13, Phase 2 12, Phase 1 3)

Trials that list this site and are registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table). The table below lists the same counts, most recent years first.

Trials started per year
Year Trials started
2026 (partial year) 34
2025 59
2024 72
2023 60
2022 86
2021 62
2020 78
2019 64
2018 78
2017 76

Showing 10 of 33 years.

Start your 14-day trial Email me all 33 years as a PDF

2026 is partial: trials registered with a 2026 start date so far, not a full year

Recent trials

The newest registered trials that list this site. Each title opens its ClinicalTrials.gov record.

Showing 5 of 1,285 trials.

Start your 14-day trial Email me the first 50 trials as a PDF

Source: ClinicalTrials.gov

Lead sponsors

Most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.

Showing 5 of 312 lead sponsors.

Start your 14-day trial Email me the first 50 lead sponsors as a PDF

Conditions studied

The specific conditions of the trials that list this site, most trials first.

Showing 5 of 519 conditions.

Start your 14-day trial Email me the first 50 conditions as a PDF